These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12689746)

  • 81. Automated on-line dialysis, trace enrichment and high-performance liquid chromatography. Inhibition of interaction with the dialysis membrane and disruption of protein binding in the determination of clozapine in human plasma.
    Johansen K; Krogh M; Rasmussen KE
    J Chromatogr B Biomed Sci Appl; 1997 Mar; 690(1-2):223-31. PubMed ID: 9106047
    [TBL] [Abstract][Full Text] [Related]  

  • 82. No effect of reboxetine on plasma concentrations of clozapine, risperidone, and their active metabolites.
    Spina E; Avenoso A; Scordo MG; Ancione M; Madia A; Levita A
    Ther Drug Monit; 2001 Dec; 23(6):675-8. PubMed ID: 11802103
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Determination of clozapine in serum by radioreceptor assay versus high-performance liquid chromatography: possible detection of hydroxy-metabolites.
    Odou P; Frimat B; Fontaine B; Luyckx M; Brunet C; Robert H; Dine T; Gressier B; Cazin M; Cazin JC
    J Clin Pharm Ther; 1996 Oct; 21(5):337-42. PubMed ID: 9119916
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum.
    Fisher DS; Partridge SJ; Handley SA; Flanagan RJ
    Forensic Sci Int; 2013 Jun; 229(1-3):151-6. PubMed ID: 23570966
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A review of the use of clozapine levels to guide treatment and determine cause of death.
    Stark A; Scott J
    Aust N Z J Psychiatry; 2012 Sep; 46(9):816-25. PubMed ID: 22327098
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Plasma, oral fluid, and whole-blood distribution of antipsychotics and metabolites in clinical samples.
    Fisher DS; van Schalkwyk GI; Seedat S; Curran SR; Flanagan RJ
    Ther Drug Monit; 2013 Jun; 35(3):345-51. PubMed ID: 23666566
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effect of fluoxetine on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenia.
    Spina E; Avenoso A; Facciolà G; Fabrazzo M; Monteleone P; Maj M; Perucca E; Caputi AP
    Int Clin Psychopharmacol; 1998 May; 13(3):141-5. PubMed ID: 9690983
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Measurement of clozapine and norclozapine in plasma/serum by high performance liquid chromatography with ultraviolet detection.
    McCarthy PT; Hughes S; Paton C
    Biomed Chromatogr; 1995; 9(1):36-41. PubMed ID: 7734932
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites.
    Centorrino F; Baldessarini RJ; Flood JG; Kando JC; Frankenburg FR
    Am J Psychiatry; 1995 Apr; 152(4):610-2. PubMed ID: 7694912
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Determination of pharmacokinetic properties of clozapine and norclozapine in Korean schizophrenia patients.
    Lee ST; Ryu S; Nam HJ; Lee SY; Hong KS
    Int Clin Psychopharmacol; 2009 May; 24(3):139-44. PubMed ID: 19194306
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A target-dose finding study of clozapine in patients with schizophrenia.
    Bennett JA; Keck PE
    Ann Clin Psychiatry; 1996 Mar; 8(1):19-21. PubMed ID: 8743644
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The usefulness of monitored therapy using Clozapine concentration in the blood serum for determining drug dose in Polish schizophrenic patients.
    Piwowarska J; Radziwoń-Zaleska M; Dmochowska M; Szepietowska E; Matsumoto H; Sygitowicz G; Pilc A; Łukaszkiewicz J
    Pharmacol Rep; 2016 Dec; 68(6):1120-1125. PubMed ID: 27588387
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Clozapine monitoring: plasma or serum levels?
    Kaladjian A; Bery B; Deturmeny E; Bruguerolle B
    Ther Drug Monit; 1999 Jun; 21(3):327-9. PubMed ID: 10365647
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A Kinetic Model for Simultaneous Fit of Clozapine and Norclozapine Concentrations in Chronic Schizophrenic Patients during Long-Term Treatment.
    Guitton C; Kinowski JM; Gomeni R; Bressolle F
    Clin Drug Investig; 1998; 16(1):35-43. PubMed ID: 18370516
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Increasing the clozapine: norclozapine ratio with co-administration of fluvoxamine to enhance efficacy and minimize side effects of clozapine therapy.
    Légaré N; Grégoire CA; De Benedictis L; Dumais A
    Med Hypotheses; 2013 Jun; 80(6):689-91. PubMed ID: 23490199
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Plasma ratio of clozapine to N-desmethylclozapine can predict cognitive performance in treatment-resistant psychotic patients.
    Molins C; Carceller-Sindreu M; Navarro H; Carmona C; Piñeiro M; Martínez E; Álvarez E; Portella MJ
    Psychiatry Res; 2017 Dec; 258():153-157. PubMed ID: 29024893
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Plasma levels of clozapine and desmethylclozapine are unaffected by concomitant ingestion of grapefruit juice.
    Vandel S; Netillard C; Perault MC; Bel AM
    Eur J Clin Pharmacol; 2000 Jul; 56(4):347-8. PubMed ID: 10954351
    [No Abstract]   [Full Text] [Related]  

  • 98. Effect of Valproate and Antidepressant Drugs on Clozapine Metabolism in Patients With Psychotic Mood Disorders.
    Marazziti D; Palego L; Betti L; Giannaccini G; Massimetti E; Baroni S; Ciapparelli A; Lucacchini A; Mucci F; DellʼOsso L
    Ther Drug Monit; 2018 Aug; 40(4):443-451. PubMed ID: 29601407
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Determination of clozapine, desmethylclozapine and clozapine N-oxide in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection.
    Avenoso A; Facciolà G; Campo GM; Fazio A; Spina E
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 714(2):299-308. PubMed ID: 9766870
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels.
    Wehring HJ; Elsobky T; McEvoy JP; Vyas G; Richardson CM; McMahon RP; DiPaula BA; Liu F; Sullivan K; Buchanan RW; Feldman S; McMahon EM; Kelly DL
    Psychiatr Q; 2018 Mar; 89(1):73-80. PubMed ID: 28466366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.